Year None20232022202120202019 News Release February 21, 2023 CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat News Release January 9, 2023 CinCor Pharma to be Acquired by AstraZeneca
Year None20232022202120202019 News Release February 21, 2023 CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat News Release January 9, 2023 CinCor Pharma to be Acquired by AstraZeneca
News Release February 21, 2023 CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
